Loading organizations...
Loading organizations...
Biopharmaceutical company developing small molecule therapeutics.
ProJenX has raised $21.1M across 3 funding rounds.
ProJenX has raised $21.1M in total across 3 funding rounds.
ProJenX has raised $21.1M in total across 3 funding rounds.
ProJenX's investors include ALS Association, Medical Excellence Capital.
ProJenX has raised $21.1M across 3 funding rounds. Most recently, it raised $1.0M Grant in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 20, 2024 | $1.0M Grant | ALS Association | |
| Nov 2, 2023 | $15.0M Series A | ||
| Feb 16, 2022 | $5.1M Seed | Medical Excellence Capital |